As far as it regards JNK inhibitors in the control of cell migration and invasion, it has been reported that JNK2-selective peptide inhibitors inhibited breast cancer cell migration [32] and that JNK suppression inhibited cell migration in human LoVo colon cancer cells [33]. This evidence concerns the gene MAPK9 and malignant colon neoplasm.